Skip to Main Content

Testing Ultrasound as a new Treatment for Diabetes

  • Study HIC#:2000034954
  • Last Updated:03/01/2024

Do you have early-stage Type 2 Diabetes?

Testing Ultrasound as a new Treatment for Diabetes

If you are an individual with early-stage Type 2 Diabetes, with an HbA1C over 6.5%, are between the ages of 18-80, and are not on any injectable diabetes medicine, you may be eligible to participate in a free and confidential study that is being conducted at the Yale Diabetes Center to help learn more about the effects of ultrasound on lowering the body’s glucose (sugar) levels.

Compensation up to $500 for 4 study visits.

For more details:

    Contact Us

    For more information about this study, including how to volunteer, contact:

    Diabetes Research at Yale

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.

    Eligibility Criteria

    An individual with early-stage Type 2 Diabetes,

    with an HbA1C over 6.5%, are between the ages of 18-80,

    and are not on any injectable diabetes medicine.

    Sub-Investigators

    • Margarita Revzin

    For more information about this study, including how to volunteer, contact: